MMSI250117P65000
- 0.00
- 0.000.00%
Merit Medical Systems Newsroom
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $114
Merit Medical Systems: Promising Growth With Wrapsody Device Approval and Market Expansion
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Merit Medical Systems Analyst Ratings
With EPS Growth And More, Merit Medical Systems (NASDAQ:MMSI) Makes An Interesting Case
Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Express News | Merit Medical Announces FDA Approval of the Wrapsody Cell-Impermeable Endoprosthesis
Merit Medical Systems Announces Leadership Change Amid Investigation
Express News | Merit Medical Systems- in Connection With . Wright's Resignation, Entered Separation Agreement Dated Dec 16
Price Over Earnings Overview: Merit Medical Systems
Merit Financial Advisors Partners With Roth Asset Management and Expands Presence in Pacific Northwest
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $120
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
Positive Outlook for Merit Medical Systems Amid Leadership Transition and Imminent Wrapsody Approval
Merit Medical Systems President Joseph Wright Resigns Amid Probe Over Conduct